Alx Oncology Holdings (ALXO) Assets Average (2020 - 2026)

Alx Oncology Holdings has reported Assets Average for 7 years, with the latest figure at $118.7 million in Q1 2026.

• Quarterly Assets Average fell 11.65% year-over-year to $118.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $118.7 million (down 11.65% YoY) and the FY2025 annual result came in at $103.4 million, down 47.01% from the prior year.
• Assets Average rose to $118.7 million in Q1 2026 per ALXO's latest filing, from $70.9 million in the prior quarter.
• Over five years, Assets Average peaked at $371.9 million in Q1 2022 and troughed at $70.9 million in Q4 2025.
• A 5-year average of $218.7 million and a median of $227.6 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2025 and 2026: Assets Average tumbled 57.49% in 2025, then retreated 11.65% in 2026.
• Over 5 years, Assets Average stood at $312.1 million in 2022, then fell by 25.88% to $231.3 million in 2023, then decreased by 27.92% to $166.7 million in 2024, then sank by 57.49% to $70.9 million in 2025, then jumped by 67.44% to $118.7 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $118.7 million, $70.9 million, and $89.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.